Related Experiment Video

Updated: Apr 11, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

1.4K

Glutaminolysis and autophagy in cancer

Victor H Villar1, Faten Merhi, Mojgan Djavaheri-Mergny

  • 1a Institut Européen de Chimie et Biologie ; Pessac , France.

Autophagy
|June 10, 2015
PubMed

Insights

Cancer cells exploit glutaminolysis for energy. Targeting this pathway, along with autophagy, offers new therapeutic strategies to overcome treatment resistance and prevent tumor relapse.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Cellular Biology

Background:

  • Cancer cells exhibit distinct metabolic profiles compared to normal cells, presenting opportunities for targeted therapies.
  • Glutaminolysis, a key metabolic pathway, is upregulated in cancer cells, providing them with significant energetic advantages.
  • The mechanistic target of rapamycin complex 1 (MTORC1) mediates a crucial link between glutaminolysis and autophagy.

Purpose of the Study:

  • To review the mechanistic link between glutaminolysis and autophagy in cancer.
  • To discuss the impact of these interconnected processes on cancer progression.
  • To explore the potential of targeting glutaminolysis and autophagy for therapeutic intervention.

Main Methods:

  • Literature review summarizing current research on glutaminolysis, autophagy, and MTORC1 in cancer.
  • Analysis of the interplay between metabolic pathways and cellular degradation processes in neoplastic cells.
  • Discussion of potential therapeutic strategies based on combined targeting of cell signaling, metabolism, and autophagy.

Main Results:

  • Upregulation of glutaminolysis confers an energetic advantage to cancer cells.
  • The MTORC1-mediated connection between glutaminolysis and autophagy represents a promising therapeutic target.
  • Combined therapies targeting cell signaling, cancer metabolism, and autophagy may overcome therapy resistance and tumor relapse.

Conclusions:

  • The interplay between glutaminolysis and autophagy, regulated by MTORC1, is critical for cancer cell survival and progression.
  • Simultaneous targeting of these pathways offers a promising strategy to combat therapeutic resistance and prevent tumor recurrence.
  • Further research into combined therapeutic approaches holds significant potential for improving patient outcomes in cancer treatment.
Keywords:
MTORROSautophagycancerglutaminolysisprolyl hydroxylasesα-ketoglutarate

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.6K
Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

18.6K

Related Concept Videos

Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.6K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.5K